LMAN2

Vesicular integral-membrane protein VIP36 · Q12907 · LMAN2 on Sugi Atlas →

0 patent compounds predicted against LMAN2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to LMAN2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients PHASE1UNKNOWN
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris nanRECRUITING
Transcriptomic Profile of Patients Treated With Different Modalities of Spinal Cord Stimulation nanUNKNOWN
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
The Natural History of Alpha-Mannosidosis nanCOMPLETED
The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients nanRECRUITING
Glucose-dependent Asprosin Dynamics nanCOMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Family Blood Pressure Program - HyperGEN nanCOMPLETED
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans nanUNKNOWN
Study of Usher Syndromes, Type 1 and Type 2 nanCOMPLETED
Affective Touch, Hedonia and Suicidal Behavior nanCOMPLETED
Identification of Biomarkers for Early Detection of Pancreatic Cancer nanCOMPLETED
Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing nanUNKNOWN
Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects nanWITHDRAWN
Family Blood Pressure Program - GENOA nanCOMPLETED
Family Blood Pressure Program - SAPPHIRe Network nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Serum NGAL IN Patients With Multiple Myeloma nanUNKNOWN
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside nanUNKNOWN
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms nanCOMPLETED
Genetic Variation in CLTCL1 and Whole-body Glucose Control nanCOMPLETED
Protein Synthesis in the Brain of Patients With Fragile X Syndrome nanCOMPLETED
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors nanNOT_YET_RECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Predicting Postoperative Delirium Using EEG, Genetics and Neurobiomarkers of Cerebral Injury nanCOMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Intestinal-Specific Organ Function Assessment (iSOFA Study) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a LMAN2 binder may also engage these)

ProteinNameSimilarity
P49256 1.000 P49256 →
Q9DBH5 0.996 Q9DBH5 →
Q62902 0.969 Q62902 →
O13097 0.964 O13097 →
Q8BJQ9 0.964 Q8BJQ9 →
P52795 0.963 P52795 →
Q5NVB3 0.963 Q5NVB3 →
O73874 0.962 O73874 →
Q9EPS3 0.960 Q9EPS3 →
Q9TU32 0.960 Q9TU32 →
Q6EV76 0.960 Q6EV76 →
A1A4K5 0.960 A1A4K5 →
F1QR43 0.960 F1QR43 →
Q9HCM2 0.959 Q9HCM2 →
O94923 0.959 O94923 →
A8WCC4 0.958 A8WCC4 →
Q9D0F3 0.958 Q9D0F3 →
O15041 0.957 O15041 →
Q9NRA1 0.957 Q9NRA1 →
Q5REF6 0.957 Q5REF6 →
Q6ZQI3 0.957 Q6ZQI3 →
O70309 0.957 O70309 →
P11456 0.957 P11456 →
Q6P9A2 0.956 Q6P9A2 →
Q9EQX6 0.956 Q9EQX6 →
P79282 0.956 P79282 →
Q6INX3 0.956 Q6INX3 →
Q66PG2 0.956 Q66PG2 →
CSGALNACT1 Chondroitin sulfate N-acetylgalactosaminyltransferase 1 0.956 landscape →
Q9NQZ7 0.955 Q9NQZ7 →